Dice Thinks It Holds An Ace With Oral IL-17 Inhibitor In Psoriasis

 
• By Jessica Merrill
  
dice
Dice Therapeutics' oral IL-17 inhibitor showed encouraging early data • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D